But the head of another biomedical research advocacy group, Research!America CEO Mary Woolley, said although her group, based in Alexandria, Virginia, is «pleased» by what it calls «a starting point,» her group feels the new initiatives
at NIH «should supplement, not supplant, the imperative of
making up for a decade's worth of
lost ground.»